His main research concerns Immunology, Transplantation, Congenital cytomegalovirus infection, Internal medicine and Ganciclovir. He combines subjects such as Liver transplantation and Disease with his study of Immunology. He works in the field of Transplantation, namely Organ transplantation.
His Congenital cytomegalovirus infection research integrates issues from Solid organ transplantation and Intensive care medicine. His research in Internal medicine intersects with topics in Gastroenterology, Antibacterial agent and Surgery. His work in Ganciclovir addresses issues such as Risk factor, which are connected to fields such as Transplant rejection.
Immunology, Transplantation, Internal medicine, Congenital cytomegalovirus infection and Gastroenterology are his primary areas of study. His study in Immunology is interdisciplinary in nature, drawing from both Disease and Virology. His work deals with themes such as Valganciclovir, Ganciclovir and Intensive care medicine, which intersect with Transplantation.
His is involved in several facets of Internal medicine study, as is seen by his studies on Liver transplantation, Incidence, Lung, Cohort and Interquartile range. His Liver transplantation research incorporates elements of Hepatitis C, Hepatitis C virus, Single-nucleotide polymorphism and Hepatitis. His Congenital cytomegalovirus infection study which covers Hematopoietic stem cell transplantation that intersects with Hematopoietic stem cell.
Raymund R. Razonable spends much of his time researching Internal medicine, Coronavirus disease 2019, Intensive care medicine, Gastroenterology and Transplantation. His Internal medicine research incorporates themes from Valganciclovir and Antifungal. The Valganciclovir study which covers Viral load that intersects with Foscarnet, Opportunistic infection, Cidofovir and Ganciclovir.
His biological study spans a wide range of topics, including Clinical trial, Sarilumab, Hydroxychloroquine, Immunosuppression and Drug resistance. Disease is closely connected to Tuberculosis in his research, which is encompassed under the umbrella topic of Immunosuppression. His research integrates issues of Congenital cytomegalovirus infection, Complication, Graft-versus-host disease, Kidney transplantation and Allograft rejection in his study of Gastroenterology.
The scientist’s investigation covers issues in Internal medicine, Clinical trial, Intensive care medicine, Adverse effect and Coronavirus disease 2019. His Internal medicine research includes themes of Valganciclovir and Viral load. The various areas that Raymund R. Razonable examines in his Viral load study include Liver transplantation, Antibiotic prophylaxis, Incidence, Randomized controlled trial and Neutropenia.
His Clinical trial study combines topics in areas such as Immunosuppression, Tuberculosis, Disease, Favipiravir and Drug resistance. His Intensive care medicine study incorporates themes from Lopinavir/ritonavir, Sarilumab, Hydroxychloroquine, Tocilizumab and Review article. His studies deal with areas such as Retrospective cohort study, Infusion therapy, Monoclonal antibody and Pneumonia as well as Adverse effect.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cytomegalovirus in Solid Organ Transplantation
R. R. Razonable;A. Humar.
American Journal of Transplantation (2013)
Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials.
Per Ljungman;Per Ljungman;Michael Boeckh;Michael Boeckh;Hans H Hirsch;Filip Josephson.
Clinical Infectious Diseases (2017)
Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: A multicentre cohort study
Deepali Kumar;Marian G. Michaels;Michele I. Morris;Michael Green.
Lancet Infectious Diseases (2010)
Chromosomally integrated human herpesvirus 6: questions and answers
Philip E. Pellett;Dharam V. Ablashi;Peter F. Ambros;Henri Agut.
Reviews in Medical Virology (2012)
Delayed-Onset Primary Cytomegalovirus Disease and the Risk of Allograft Failure and Mortality after Kidney Transplantation
Supha K. Arthurs;Albert J. Eid;Rachel A. Pedersen;Walter K. Kremers.
Clinical Infectious Diseases (2008)
Serious infections caused by methicillin-resistant Staphylococcus aureus.
Helen Boucher;Loren G. Miller;Raymund R. Razonable.
Clinical Infectious Diseases (2010)
Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.
Kelly W. Burak;Walter K. Kremers;Kenneth P. Batts;Russell H. Wiesner.
Liver Transplantation (2002)
Allograft Rejection Predicts the Occurrence of Late-Onset Cytomegalovirus (CMV) Disease among CMV-Mismatched Solid Organ Transplant Patients Receiving Prophylaxis with Oral Ganciclovir
Raymund R. Razonable;Antonio Rivero;Aurelio Rodriguez;Jennie Wilson.
The Journal of Infectious Diseases (2001)
Cytomegalovirus infections in solid organ transplantation: a review.
Poornima Ramanan;Raymund R Razonable.
Infection and Chemotherapy (2013)
New developments in the management of cytomegalovirus infection after solid organ transplantation.
Albert J. Eid;Raymund R. Razonable.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: